tm logo
GLIMMUNE THERAPEUTICS
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 02 Dec 2024

Last Applicant/ Owned by

2/B Mahalaxmi Chamber 22 Bhulabhai Desai

Mumbai

IN

400026

Serial Number

97917473 filed on 02th May 2023

Registration Number

N/A

Correspondent Address

Maxim A. Voltchenko

MAXIM A. VOLTCHENKO KAPLAN BREYER SCHWARZ, LLP

SOUTH WING

EAST BRUNSWICK, NJ 08816

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

GLIMMUNE THERAPEUTICS

Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; Opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and sub Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; Opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain; preparations for the treatment of asthma


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97917473

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 4007-114TMUS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th Dec 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02th Dec 2024ABANDONMENT - NO USE STATEMENT FILED
30th Apr 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Mar 2024PUBLISHED FOR OPPOSITION
14th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14th Feb 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26th Jan 2024APPROVED FOR PUB - PRINCIPAL REGISTER
23rd Jan 2024ASSIGNED TO EXAMINER
31st May 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED